|
| Date |
Type |
Disease |
Title |
|
Jul 13, 2008 |
Article |
CFIDS&FM |
How biological abnormalities separate ME/CFS (chronic fatigue syndrome) from depression
"Chronic fatigue syndrome [ME/CFS] and depression share symptoms and may coexist," but based on the scientific findings cited in this educational article, "skilled clinicians can now more easily tell them apart." |
|
Jul 11, 2008 |
Chat |
CFIDS&FM |
Letters From Our Readers - Comments & Suggestions 07-16-08
Letters From Our Readers - Comments & Suggestions 07-16-08 |
|
Jul 11, 2008 |
Chat |
CFIDS&FM |
Letters From Our Readers - Q&A Session 07-16-08
Letters From Our Readers - Q&A Session 07-16-08 |
|
Jul 11, 2008 |
Article,ClinicalTrial,Events |
CFIDS&FM |
National ME/CFS Genetic Risk Factor Study Needs 400 Participants
Researchers at Tufts University, Boston, and the University of Illinois at Chicago are issuing a national call for ME/CFS (chronic fatigue syndrome) patients in the U.S., ages 13 through 64. |
|
Jul 11, 2008 |
Article |
CFIDS&FM |
A clinician’s guide to the implications of ME/CFS (chronic fatigue syndrome) for women during their childbearing years – current science and expert opinion
This outstanding guide for women with ME/CFS and their clinicians draws on the knowledge and thinking of the most trusted names in ME/CFS/FM care. It includes an education about the illness based on the latest research, and in that context outlines clinical practice recommendations from preconception to postpartum care. |
|
Jul 09, 2008 |
Abstract |
CFIDS&FM |
Identification of Marker Genes for Differential Diagnosis of Chronic Fatigue Syndrome – Source: Molecular Medicine, Jul 3, 2008; free access article in PubMed
Gene analysis identifies cluster of 9 genes that are “significantly changed” in ME/CFS patients vs. healthy individuals – including “energy regulators” - and show promise as a means of distinguishing individuals with ME/CFS from those with other "long-lasting fatigue conditions" in the majority of cases. [Source: Molecular Medicine, Jul 3, 2008; free access article in PubMed] |
|
Jul 08, 2008 |
Article |
CFIDS&FM |
FDA accepts antiviral drug AmpligenR for review as first-ever ME/CFS (‘chronic fatigue syndrome’) therapeutic
After 30 years in development and testing, the experimental “antiviral/immune modulatory” drug AmpligenR has been accepted by the FDA for review as potentially the first prescription drug approved in the U.S. for treatment of ME/CFS – specifically for certain patients with severe ME/CFS. |
|
Jul 02, 2008 |
Abstract |
CFIDS&FM |
Chronic Fatigue Syndrome: Implications for Women and their Health Care Providers During the Childbearing Years – Source: Journal of Midwifery and Children’s Health, Jul-Aug 2008
Much-needed healthcare provider guidelines for the care of women with ME/CFS during pregnancy, labor and birth, lactation, and the postpartum period. Expert opinion referencing current scientific evidence, by a highly-regarded women’s health educator. [Source: Journal of Midwifery and Children’s Health, Jul-Aug 2008] |
|
Jul 01, 2008 |
Article,ClinicalTrial,Events |
CFIDS&FM |
UCLA – Trial of drug to improve cognition & function in adults with depression, ages 60 and older (not yet recruiting)
This 16-week NIH-sponsored study at UCLA – Effectiveness of Methylphenidate in Improving Cognition and Function in Older Adults with Depression - will recruit patients age 60 and older. |
|
Jun 28, 2008 |
Article |
CFIDS&FM |
Dr. David Bell Reports “Snippets of Wonderful Science that Caught My Attention,” from the 2008 International HHV-6 Conference
What’s HHV-6? A ubiquitous herpes virus that is integrated into the chromosomes of nearly 1% of all newborns, causes roseola in small children, can infect/reside in many types of cells including the lining of blood vessels, can re-activate with stress, and “has a strong association with many diseases of the central nervous system,” Dr. Bell explains. |
|
|
Next 10 Articles>> |
|
|
|
